Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 4:32 pm Purchase | 2025-02-07 | 13G | Ikena Oncology, Inc. IKNA | Deep Track Capital LP | 2,515,513 5.210% | 2,515,513 (New Position) | Filing History |
| 2025-02-14 4:22 pm Sale | 2024-12-31 | 13G | Ikena Oncology, Inc. IKNA | BIOTECHNOLOGY VALUE FUND L P | 4,006,564 8.300% | -762,600 (-15.99%) | Filing History |
| 2025-02-14 10:47 am Unchanged | 2024-12-31 | 13G | Ikena Oncology, Inc. IKNA | BML Investment Partners L.P. | 3,645,866 7.600% | 0 (Unchanged) | Filing History |
| 2025-02-13 4:22 pm Sale | 2024-12-31 | 13G | Ikena Oncology, Inc. IKNA | GILEAD SCIENCES INC GILD | 1,521,312 3.600% | -1,410,155 (-48.10%) | Filing History |
| 2024-12-31 3:44 pm Purchase | 2024-12-23 | 13G | Ikena Oncology, Inc. IKNA | BML Investment Partners L.P. | 3,645,866 7.600% | 3,645,866 (New Position) | Filing History |
| 2024-11-14 5:05 pm Purchase | 2024-09-30 | 13G | Context Therapeutics Inc. CNTX | Blue Owl Capital Holdings LP | 4,091,118 8.480% | 4,091,118 (New Position) | Filing History |
| 2024-11-13 4:05 pm Unchanged | 2024-09-30 | 13G | Ikena Oncology, Inc. IKNA | BRISTOL MYERS SQUIBB CO BMY | 2,133,142 4.400% | 0 (Unchanged) | Filing History |
| 2024-03-11 08:19 am Sale | 2024-03-08 | 13G | Ikena Oncology, Inc. IKNA | FMR LLC | 1,215,002 2.771% | -2,969,291 (-70.96%) | Filing History |
| 2024-02-14 4:57 pm Sale | 2023-12-31 | 13G | Ikena Oncology, Inc. IKNA | CITADEL ADVISORS LLC | 178,177 0.400% | -1,976,957 (-91.73%) | Filing History |
| 2024-02-14 4:48 pm Unchanged | 2023-12-31 | 13G | Ikena Oncology, Inc. IKNA | Omega Fund VI L.P. | 2,249,123 4.700% | 0 (Unchanged) | Filing History |
| 2024-02-14 09:47 am Purchase | 2023-12-31 | 13G | Ikena Oncology, Inc. IKNA | BIOTECHNOLOGY VALUE FUND L P | 4,769,164 9.900% | 2,266,093 (+90.53%) | Filing History |
| 2024-02-09 09:16 am Purchase | 2024-02-08 | 13G | Ikena Oncology, Inc. IKNA | FMR LLC | 4,184,293 9.545% | 459,718 (+12.34%) | Filing History |
| 2023-10-19 3:33 pm Purchase | 2023-10-11 | 13G | Ikena Oncology, Inc. IKNA | GILEAD SCIENCES INC GILD | 2,931,467 6.700% | 2,931,467 (New Position) | Filing History |
| 2023-09-21 4:52 pm Sale | 2023-08-04 | 13D | Ikena Oncology, Inc. IKNA | ORBIMED ADVISORS LLC | 2,189,111 5.200% | -153,121 (-6.54%) | Filing History |
| 2023-09-14 4:21 pm Purchase | 2023-08-04 | 13D | Ikena Oncology, Inc. IKNA | ORBIMED ADVISORS LLC | 2,342,232 5.500% | 405,346 (+20.93%) | Filing History |
| 2023-02-14 08:02 am Purchase | 2022-12-31 | 13G | Ikena Oncology, Inc. IKNA | CITADEL ADVISORS LLC | 2,155,134 5.900% | 26,926 (+1.27%) | Filing History |
| 2023-02-13 6:11 pm Purchase | 2022-12-31 | 13G | Ikena Oncology, Inc. IKNA | BIOTECHNOLOGY VALUE FUND L P | 2,503,071 6.900% | 704,700 (+39.19%) | Filing History |
| 2023-01-10 12:48 pm Purchase | 2023-01-09 | 13G | Ikena Oncology, Inc. IKNA | FMR LLC | 3,724,575 10.272% | 1,198,372 (+47.44%) | Filing History |
| 2022-10-11 09:03 am Sale | 2022-10-07 | 13G | Ikena Oncology, Inc. IKNA | FMR LLC | 2,526,203 6.967% | -2,197,484 (-46.52%) | Filing History |
| 2022-02-14 2:57 pm Purchase | 2021-12-31 | 13G | Ikena Oncology, Inc. IKNA | Omega Fund VI L.P. | 2,249,123 6.300% | 2,249,123 (New Position) | Filing History |